Rising Oil Prices and Their Impact on Medicine Manufacturing Costs
Increased oil prices may significantly hike the cost of certain medicines, highlighting the need to reduce reliance on petrochemicals for production.
July 30, 2026
Technology
Latest technology news and innovations
FDA Panel Rejects Duchenne Treatment as FTC Targets Hims & Hers Practices
A recent FDA panel's critical vote against a Duchenne drug highlights ongoing scrutiny of digital health practices, particularly Hims & Hers.
July 30, 2026
Latigo Biotherapeutics Shows Promise with Non-Opioid Pain Relief Drug in Phase 2 Trial
Latigo Biotherapeutics' LTG-001 demonstrates significant pain relief in Phase 2 trials, marking a potential shift in non-opioid pain management options.
July 29, 2026
FTC Targets Hims for Misleading Practices and Privacy Violations
The FTC has initiated a lawsuit against Hims & Hers, accusing the telehealth firm of deceptive practices in consumer health data handling.
July 29, 2026
Biotech Executive's Secret Identity and Legal Battle Over Eli Lilly's Pricing Policies
A fugitive assumed a new life in biotech, while a New Hampshire hospital challenges Eli Lilly's controversial pricing policies under the 340B program.
July 29, 2026
Understanding the Complexities of Benchmarking Clinical AI Systems
The debate over benchmarking clinical AI systems highlights the challenges of interpreting results beyond headlines.
July 29, 2026
Capricor's Duchenne Treatment Faces Scrutiny as FDA Committee Reviews Efficacy
The FDA's expert committee reviews Capricor's deramiocel, a potential Duchenne treatment, raising questions about its efficacy and trial integrity.
July 29, 2026
Trusting Clinical AI: A Showdown Between Clinical and Generalist Models
A recent study reveals clinical AI models underperform compared to generalist models, sparking debate in the health AI community.
July 29, 2026
Mysterious Biotech Figure's History of Concealment Raises Questions on Hiring Practices
The revelation of a fugitive's secret biotech career sparks scrutiny over hiring practices and vetting processes in the industry.
July 29, 2026
Marking 50 Years of Viking 1: Insights from This Week In Space Podcast
Explore the legacy of Viking 1's Mars landing as experts discuss its findings and the latest developments in space exploration.
July 25, 2026
Ethical Implications Raised by Experimental CRISPR Therapy Incident in China
A tragic incident involving a six-year-old girl’s death from experimental CRISPR therapy in China has sparked urgent ethical discussions in biotech.
July 24, 2026
FDA Panel Weighs In on Peptides, While Sanofi Faces Supply Issues with Insulin Pen
An FDA advisory panel endorses peptide accessibility, while Sanofi's insulin pen faces supply shortages, impacting diabetes patients nationwide.
July 24, 2026
Merck Initiates Voluntary Licensing for Experimental HIV Prevention Pill in Developing Countries
Merck has signed licensing agreements with seven companies to produce and distribute a generic version of its experimental HIV prevention pill in 129 countries.
July 24, 2026
European Medicines Agency Accelerates Efforts for Clinical Trial Result Disclosure
The European Medicines Agency is swiftly advancing clinical trial transparency, responding to concerns over low reporting compliance in a key database.
July 23, 2026
Supply Issues Hit Sanofi's Lantus Solostar Insulin Pen Amid Rising Demand
Patients relying on Sanofi's Lantus Solostar insulin pen face challenges due to increased demand and supply shortages, with improvements expected soon.
July 23, 2026
FDA Faces Critical Decisions on Compounded Peptides Amid Rising Concerns
The FDA deliberates on the regulation of compounded peptides as public health implications come to the forefront, alongside key pharmaceutical advances.
July 23, 2026
Timothy Westlake Nominated to Lead SAMHSA as Mental Health Agency's New Head
President Trump's nomination of Timothy Westlake for SAMHSA marks a pivotal moment for U.S. mental health and addiction policies.
July 23, 2026
Eli Lilly's Obesity Drug Achieves Weight Loss Success, but Cardiovascular Benefits Remain Unclear
Eli Lilly's retatrutide shows significant weight loss in obesity trials, but questions linger about its cardiovascular risks despite its promising results.
July 23, 2026
Experts Call for Unified Standards in Clinical AI Evaluation
The White House and HHS gather specialists to establish unified principles for evaluating clinical AI technologies.
July 23, 2026
Public Citizen Calls for Ban on Direct-to-Consumer Prescription Drug Advertising
Public Citizen petitions the FDA to prohibit direct-to-consumer drug ads, claiming they mislead consumers and prioritize persuasion over education.
July 23, 2026